On January 14, 2013, Genesis Biopharma, Inc.’s (the “Company”) Chief Executive Officer Anthony J. Cataldo, with the consent of the Company’s Board of Directors, undertook a leave of absence from his position as the Company’s Principal Executive Officer without prejudice to his rights under his employment agreement. During the leave of absence, Mr. Cataldo will remain a director of the Company
With consent of Board.... You go Guy....
Undertook a leave of absence.. Reason? Maybe it was his health. All the questions were making him sick...
Without prejudice to his right under his employment agreement.. I guess Tony still wants to keep his $ 300,000 a year salary and his millions of shares of free stock..
OK Merrill its your turn . How about 10Q that was due on 11-14-2012.
